Intracranial aneurysms may exist in approximately 3% of the American population, and 6-7% of the Chinese population, which is the main cause of nontraumatic subarachnoid hemorrhage. Immunology and inflammation are essential for occurring and progress of the cerebrovascular disease. Recently, more and more studies revealed that the relative immunological and inflammatory factors or relative molecules serve as a predictor of progress or outcome of intracranial aneurysms, or could be a candidate for preventing intracranial aneurysm from progression. However, there are still few relevant studies to find the role of immunology and inflammation on the progression of intracranial aneurysms. This Research Topic aims to discuss the role of immunology and inflammation in aneurysms and improve the accurate treatment for this disease.
The goal of this Topic is to discuss the immunological characteristics of intracranial aneurysms, new biomarkers to predict the risk of unruptured intracranial aneurysms, novel models to predict the outcome of patients with intracranial aneurysms, and potential treatment targets to prevent intracranial aneurysms from rupture or growth. We hope that this topic can provide cutting-edge insight into the role of immunology and inflammation in the intracranial aneurysm, and provide a basis for exploring the biomarker and treatment target of intracranial aneurysm. In this topic, we will also focus on the studies about clinical translation of new biomarkers or new treatment targets.
Intracranial aneurysm is the main cause of nontraumatic subarachnoid hemorrhage. For the importance of immunology and inflammation in the development and prognosis of intracranial aneurysms, the investigation on these biological processes will provide an in-depth insight into the origin and progress of intracranial aneurysms, and provide a basis to develop the biomarker and treatment target. However, there are still few relevant studies to find the role of immunology and inflammation on the progression of intracranial aneurysms. In this Research Topic, we will focus on the frontiers of immunology and inflammation in the intracranial aneurysm. Moreover, the clinical translation and this study with huge importance for future breakthroughs will be our focus.
Intracranial aneurysms may exist in approximately 3% of the American population, and 6-7% of the Chinese population, which is the main cause of nontraumatic subarachnoid hemorrhage. Immunology and inflammation are essential for occurring and progress of the cerebrovascular disease. Recently, more and more studies revealed that the relative immunological and inflammatory factors or relative molecules serve as a predictor of progress or outcome of intracranial aneurysms, or could be a candidate for preventing intracranial aneurysm from progression. However, there are still few relevant studies to find the role of immunology and inflammation on the progression of intracranial aneurysms. This Research Topic aims to discuss the role of immunology and inflammation in aneurysms and improve the accurate treatment for this disease.
The goal of this Topic is to discuss the immunological characteristics of intracranial aneurysms, new biomarkers to predict the risk of unruptured intracranial aneurysms, novel models to predict the outcome of patients with intracranial aneurysms, and potential treatment targets to prevent intracranial aneurysms from rupture or growth. We hope that this topic can provide cutting-edge insight into the role of immunology and inflammation in the intracranial aneurysm, and provide a basis for exploring the biomarker and treatment target of intracranial aneurysm. In this topic, we will also focus on the studies about clinical translation of new biomarkers or new treatment targets.
Intracranial aneurysm is the main cause of nontraumatic subarachnoid hemorrhage. For the importance of immunology and inflammation in the development and prognosis of intracranial aneurysms, the investigation on these biological processes will provide an in-depth insight into the origin and progress of intracranial aneurysms, and provide a basis to develop the biomarker and treatment target. However, there are still few relevant studies to find the role of immunology and inflammation on the progression of intracranial aneurysms. In this Research Topic, we will focus on the frontiers of immunology and inflammation in the intracranial aneurysm. Moreover, the clinical translation and this study with huge importance for future breakthroughs will be our focus.
